67 results
S-1/A
EX-10.10
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
be responsible for paying Base Rent for the period between the Commencement Date and the end of the calendar month in which the Commencement Date occurs … not be responsible for making any improvements or alterations to such ROFO Space or providing any improvement allowance with respect thereto, except
S-1
EX-10.10
CADL
Candel Therapeutics Inc
25 Jun 21
IPO registration
5:28pm
commence on the first day of the full calendar month occurring after the Commencement Date and Tenant shall be responsible for paying Base Rent … of the Premises and subject to the terms and conditions of this Lease; provided that (x) Landlord shall not be responsible for making any
8-K
EX-99.1
CADL
Candel Therapeutics Inc
8 Jun 23
Candel Therapeutics Appoints Experienced Manufacturing Leader Nicoletta Loggia, PhD, RPh to its Board of Directors
8:15am
is responsible for CMC process and analytical development, manufacturing, supply chain, distribution, and global quality.
Before Orchard, Dr. Loggia served … as Global Head of Cell and Gene Therapies at Novartis AG (Novartis), where she led multidisciplinary international teams responsible for the end
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
choose to access the proxy materials or vote over the Internet, you are responsible for any Internet access charges that you may incur. Our officers … , 2022. KPMG LLP has served as Candel’s independent registered public accounting firm since 2019.
The audit committee is solely responsible for selecting
S-3
EX-4.8
cqaxaeicj dlz
5 Aug 22
Shelf registration
5:08pm
S-3
EX-4.9
et7 c3tnzkc
5 Aug 22
Shelf registration
5:08pm
10-K
EX-31.2
qxxr3nejjnl87oyv
29 Mar 22
Annual report
8:46am
S-1
EX-10.9
evveu78odew6g7d
25 Jun 21
IPO registration
5:28pm
S-1/A
EX-10.9
9xzw fn85hl2up0f14dv
16 Jul 21
IPO registration (amended)
6:07am
10-Q
EX-31.1
5pkaze
8 Sep 21
Quarterly report
8:37am
10-Q
EX-31.2
1rtmrrgeb fsvh
8 Sep 21
Quarterly report
8:37am